Previous data observed that PCSK9 levels were increased in type 2 diabetes mellitus/metabolic syndrome patients and positive correlations of PCSK9 levels with LDL, fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c), fasting insulin, and insulin resistance (10, 11). This evidence concerns the gene PCSK9 and diabetes mellitus.